FIELD: pharmacology.
SUBSTANCE: ubiquinol composition is intended for treatment of cardiovascular system diseases and includes a medicinal substance (ubiquinol), surfactants, anti-oxidants (direct and indirect) and solvents, allowed for parenteral administration.
EFFECT: composition and the method allow to obtain a storage stable ubiquinol solution suitable for injectable administration.
10 cl, 6 dwg, 1 tbl, 24 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
| COMPOSITION WITH 6-DECAPRNYL-2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE FOR PARENTERAL INTRODUCTION AND METHOD OF ITS OBTAINING | 2009 |
|
RU2433820C2 |
| NANODISPERSE COENZYME Q10 COMPOSITION AND METHOD FOR MAKING THEREOF | 2009 |
|
RU2411027C1 |
| PROCESS FOR PRODUCTION OF REDUCED FORM OF COENZYME Q | 2016 |
|
RU2613103C1 |
| RAPID CATALYTIC METHOD FOR PREPARING RECOVERED FORM OF COENZYME Q10 TO BE USED IN PHARMACEUTICAL AND FOOD COMPOSITIONS | 2013 |
|
RU2535928C1 |
| WATER-SOLUBLE MOLECULAR INCLUSION COMPLEX OF REDUCED FORM OF COENZYME Q IN β-CYCLODEXTRIN AND METHOD FOR PREPARATION THEREOF | 2011 |
|
RU2509760C2 |
| METHOD FOR QUANTITATIVE DETERMINATION OF COENZYME Q ANTIOXIDANT IN SUBSTANCE THROUGH CYCLIC VOLTAMMETRY | 2010 |
|
RU2454660C1 |
| SOLID DISPERSIONS Q | 2016 |
|
RU2742579C2 |
| VOLT-AMMETRIC METHOD FOR DETERMINATION OF COENZYME Q10 IN COSMETIC CREAMS | 2015 |
|
RU2613897C1 |
| METHOD FOR CORRECTION OF NEUROTROPHILIC CHANGES IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AFTER CORONAVIRUS INFECTION | 2023 |
|
RU2814770C1 |
